Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Hipposideros larvatus genome sequencing

PROVIDER: PRJNA938461 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR23683929_1.fastq.gz	Fastqsanger.gz
	SRR23683929_2.fastq.gz	Fastqsanger.gz
	SRR23683930_subreads.fastq.gz	Fastqsanger.gz
	SRR23695893_subreads.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Hipposideros larvatus

Project description:Hipposideros larvatus overview

| PRJNA854727 | ENA

Hipposideros larvatus

Project description:Hipposideros larvatus alternate pseudohaplotype genome sequencing

| PRJNA937063 | ENA

Hipposideros larvatus

Project description:Hipposideros larvatus principal pseudohaplotype genome sequencing

| PRJNA937064 | ENA

Project description:Hipposideros larvatus (intermediate roundleaf bat) genome, mHipLar1

| PRJNA1009067 | ENA

Hipposideros larvatus isolate:mRhiSin1

Project description:Hipposideros larvatus (intermediate roundleaf bat) genome, mHipLar1, primary haplotype

| PRJNA776471 | ENA

Hipposideros larvatus isolate:mHipLar1

Project description:Hipposideros larvatus (intermediate roundleaf bat) genome, mHipLar1, primary haplotype

| PRJNA1006758 | ENA

Hipposideros larvatus isolate:mHipLar1

Project description:Hipposideros larvatus (intermediate roundleaf bat) genome, mHipLar1, alternate haplotype

| PRJNA1006759 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Nasalis larvatus

Project description:Nasalis larvatus Genome sequencing and assembly

| PRJNA241312 | ENA

Oriolus larvatus strain:NA

Project description:Oriolus larvatus

| PRJNA964279 | ENA